Jan Groen
Vorsitzender bei ANGLE PLC
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Ian Griffiths | M | - | 29 Jahre | |
| Andrew Newland | M | 63 | 30 Jahre | |
| Alex Batchelor | M | 54 |
OxDX Ltd.
 OxDX Ltd. Packaged SoftwareTechnology Services OxDX Ltd. builds instant pathogen test detection using resolution microscopy and machine learning. The company is based in Headington, UK. The British company was founded by Alex Batchelor, Nicolas Shiaelis, and Nicole Robb. Alex Batchelor has been the CEO since incorporation. | 3 Jahre |
| Juan J. Diaz Mochon | M | 51 |
Destina Genomics Ltd.
 Destina Genomics Ltd. BiotechnologyHealth Technology Destina Genomics Ltd. is engaged in development of molecular diagnostic products. Its products include pipeline assay kits and liverace. The company was founded by Hugh Llyine, Juan J. Diaz-Mochon and Mark Bradley in 2011 and is headquartered in Edinburgh, the United Kingdom. | 13 Jahre |
| Sahar Hosseinian | M | - |
Novigenix SA
 Novigenix SA Medical SpecialtiesHealth Technology Novigenix SA develops molecular diagnostics for cancer. The firm specializes in new generation liquid biopsy tests for early detection of cancer and precision medicine. The company was founded by Sahar Hosseinian in 2014 and is headquartered in Epalinges, Switzerland. | 10 Jahre |
| Hugh Alexander Ilyine | M | 72 |
Destina Genomics Ltd.
Destina Genomics Ltd. BiotechnologyHealth Technology Destina Genomics Ltd. is engaged in development of molecular diagnostic products. Its products include pipeline assay kits and liverace. The company was founded by Hugh Llyine, Juan J. Diaz-Mochon and Mark Bradley in 2011 and is headquartered in Edinburgh, the United Kingdom. | 13 Jahre |
| Lieve Verplancke | M | 65 | 7 Jahre | |
| Miro Venturi | M | - |
Novigenix SA
Novigenix SA Medical SpecialtiesHealth Technology Novigenix SA develops molecular diagnostics for cancer. The firm specializes in new generation liquid biopsy tests for early detection of cancer and precision medicine. The company was founded by Sahar Hosseinian in 2014 and is headquartered in Epalinges, Switzerland. | 3 Jahre |
| Brian Howlett | M | 80 | 11 Jahre | |
| Hilde Windels | F | 59 | 7 Jahre | |
| Christian Jauch | M | - |
Novigenix SA
Novigenix SA Medical SpecialtiesHealth Technology Novigenix SA develops molecular diagnostics for cancer. The firm specializes in new generation liquid biopsy tests for early detection of cancer and precision medicine. The company was founded by Sahar Hosseinian in 2014 and is headquartered in Epalinges, Switzerland. | 9 Jahre |
| Laura Ciarloni | M | - |
Novigenix SA
Novigenix SA Medical SpecialtiesHealth Technology Novigenix SA develops molecular diagnostics for cancer. The firm specializes in new generation liquid biopsy tests for early detection of cancer and precision medicine. The company was founded by Sahar Hosseinian in 2014 and is headquartered in Epalinges, Switzerland. | 10 Jahre |
| Patrik Zamecnik | M | - |
Saving Patients' Lives Medical BV
 Saving Patients' Lives Medical BV Medical SpecialtiesHealth Technology Saving Patients' Lives Medical BV develops and manufactures nano-sized iron oxide particles for effective diagnostics of cancer metastasis. The company was founded by Ari Aminetzah and Patrik Zamecnik in 2015 and is headquartered in Nijmegen, the Netherlands. | 9 Jahre |
| Brian B. Hashemi | M | - |
Novigenix SA
Novigenix SA Medical SpecialtiesHealth Technology Novigenix SA develops molecular diagnostics for cancer. The firm specializes in new generation liquid biopsy tests for early detection of cancer and precision medicine. The company was founded by Sahar Hosseinian in 2014 and is headquartered in Epalinges, Switzerland. | 9 Jahre |
| Nicolas Shiaelis | M | - |
OxDX Ltd.
OxDX Ltd. Packaged SoftwareTechnology Services OxDX Ltd. builds instant pathogen test detection using resolution microscopy and machine learning. The company is based in Headington, UK. The British company was founded by Alex Batchelor, Nicolas Shiaelis, and Nicole Robb. Alex Batchelor has been the CEO since incorporation. | 3 Jahre |
| Michael K. McGarrity | M | 62 | 5 Jahre | |
| Nathalie Laarakker | F | - |
Intravacc BV
| 3 Jahre |
| Nicole Robb | M | 41 |
OxDX Ltd.
OxDX Ltd. Packaged SoftwareTechnology Services OxDX Ltd. builds instant pathogen test detection using resolution microscopy and machine learning. The company is based in Headington, UK. The British company was founded by Alex Batchelor, Nicolas Shiaelis, and Nicole Robb. Alex Batchelor has been the CEO since incorporation. | 3 Jahre |
| Ari Aminetzah | M | - |
Saving Patients' Lives Medical BV
Saving Patients' Lives Medical BV Medical SpecialtiesHealth Technology Saving Patients' Lives Medical BV develops and manufactures nano-sized iron oxide particles for effective diagnostics of cancer metastasis. The company was founded by Ari Aminetzah and Patrik Zamecnik in 2015 and is headquartered in Nijmegen, the Netherlands. | 9 Jahre |
| Sylvain Monnier-Benoit | M | - |
Novigenix SA
Novigenix SA Medical SpecialtiesHealth Technology Novigenix SA develops molecular diagnostics for cancer. The firm specializes in new generation liquid biopsy tests for early detection of cancer and precision medicine. The company was founded by Sahar Hosseinian in 2014 and is headquartered in Epalinges, Switzerland. | 10 Jahre |
| Martin Cooke | M | - | 20 Jahre | |
| Karin Louise Dorrepaal | M | 63 |
Intravacc BV
| 7 Jahre |
| Erik Popping | M | - |
Intravacc BV
| 8 Jahre |
| Koen Hoffman | M | 56 | 6 Jahre | |
| François Martelet | M | 64 |
Novigenix SA
Novigenix SA Medical SpecialtiesHealth Technology Novigenix SA develops molecular diagnostics for cancer. The firm specializes in new generation liquid biopsy tests for early detection of cancer and precision medicine. The company was founded by Sahar Hosseinian in 2014 and is headquartered in Epalinges, Switzerland. | 5 Jahre |
| Nicholas Claxton | M | - | 5 Jahre | |
| Anne-Sophie Pailhes-Jimenez | F | - | 8 Jahre | |
| Stefan Peter | M | - | 10 Jahre | |
| Brett Swansiger | M | - | - | |
| Judith Bergboer | F | - |
Cergentis BV
 Cergentis BV Miscellaneous Commercial ServicesCommercial Services Part of Solvias AG, Cergentis BV is a Dutch genomics company that develops and commercializes TLA-based diagnostic kits for targeted complete next-generation sequencing of (trans) genes and gene editing events. The company is based in Utrecht, Netherlands. The company also provides commercial services for leading research institutes and pharmaceutical companies worldwide. The company was founded in 2012. Joris Schuurmans has been the CEO of the company since 2020. Cergentis was acquired by Solvias AG on July 12, 2022. | - |
| Wilm van Criekinge | M | - |
Cergentis BV
Cergentis BV Miscellaneous Commercial ServicesCommercial Services Part of Solvias AG, Cergentis BV is a Dutch genomics company that develops and commercializes TLA-based diagnostic kits for targeted complete next-generation sequencing of (trans) genes and gene editing events. The company is based in Utrecht, Netherlands. The company also provides commercial services for leading research institutes and pharmaceutical companies worldwide. The company was founded in 2012. Joris Schuurmans has been the CEO of the company since 2020. Cergentis was acquired by Solvias AG on July 12, 2022. | - |
| Karen Miller | F | - | 1 Jahre | |
| Nico Oudendijk | M | - |
Intravacc BV
| - |
| Maja Sanders | F | - |
Cergentis BV
Cergentis BV Miscellaneous Commercial ServicesCommercial Services Part of Solvias AG, Cergentis BV is a Dutch genomics company that develops and commercializes TLA-based diagnostic kits for targeted complete next-generation sequencing of (trans) genes and gene editing events. The company is based in Utrecht, Netherlands. The company also provides commercial services for leading research institutes and pharmaceutical companies worldwide. The company was founded in 2012. Joris Schuurmans has been the CEO of the company since 2020. Cergentis was acquired by Solvias AG on July 12, 2022. | - |
| Jorge Bensadón Beliche | M | 64 |
Destina Genomics Ltd.
Destina Genomics Ltd. BiotechnologyHealth Technology Destina Genomics Ltd. is engaged in development of molecular diagnostic products. Its products include pipeline assay kits and liverace. The company was founded by Hugh Llyine, Juan J. Diaz-Mochon and Mark Bradley in 2011 and is headquartered in Edinburgh, the United Kingdom. | - |
| Madeline Repollet | F | - | - | |
| Andrew Holder | M | - | 3 Jahre | |
| Craig Miller | M | - | 8 Jahre | |
| Salvatore Pernagall | M | - |
Destina Genomics Ltd.
Destina Genomics Ltd. BiotechnologyHealth Technology Destina Genomics Ltd. is engaged in development of molecular diagnostic products. Its products include pipeline assay kits and liverace. The company was founded by Hugh Llyine, Juan J. Diaz-Mochon and Mark Bradley in 2011 and is headquartered in Edinburgh, the United Kingdom. | - |
| Todd Snowden | M | - |
Destina Genomics Ltd.
Destina Genomics Ltd. BiotechnologyHealth Technology Destina Genomics Ltd. is engaged in development of molecular diagnostic products. Its products include pipeline assay kits and liverace. The company was founded by Hugh Llyine, Juan J. Diaz-Mochon and Mark Bradley in 2011 and is headquartered in Edinburgh, the United Kingdom. | - |
| Dirk Pollet | M | - |
Cergentis BV
Cergentis BV Miscellaneous Commercial ServicesCommercial Services Part of Solvias AG, Cergentis BV is a Dutch genomics company that develops and commercializes TLA-based diagnostic kits for targeted complete next-generation sequencing of (trans) genes and gene editing events. The company is based in Utrecht, Netherlands. The company also provides commercial services for leading research institutes and pharmaceutical companies worldwide. The company was founded in 2012. Joris Schuurmans has been the CEO of the company since 2020. Cergentis was acquired by Solvias AG on July 12, 2022. | - |
| Joseph Eid | M | 56 | 1 Jahre | |
| Juliet Thompson | F | 57 | 1 Jahre | |
| Joris Schuurmans | M | - |
Cergentis BV
Cergentis BV Miscellaneous Commercial ServicesCommercial Services Part of Solvias AG, Cergentis BV is a Dutch genomics company that develops and commercializes TLA-based diagnostic kits for targeted complete next-generation sequencing of (trans) genes and gene editing events. The company is based in Utrecht, Netherlands. The company also provides commercial services for leading research institutes and pharmaceutical companies worldwide. The company was founded in 2012. Joris Schuurmans has been the CEO of the company since 2020. Cergentis was acquired by Solvias AG on July 12, 2022. | 4 Jahre |
| Michael O'Brien | M | - | - | |
| Bruno Bruins | M | - |
Intravacc BV
| 3 Jahre |
| David Whitcombe | M | - |
Destina Genomics Ltd.
Destina Genomics Ltd. BiotechnologyHealth Technology Destina Genomics Ltd. is engaged in development of molecular diagnostic products. Its products include pipeline assay kits and liverace. The company was founded by Hugh Llyine, Juan J. Diaz-Mochon and Mark Bradley in 2011 and is headquartered in Edinburgh, the United Kingdom. | 9 Jahre |
| Daniëlle Lankveld | M | - |
Intravacc BV
| 11 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Garth Selvey | M | - | 17 Jahre | |
| Walter M. Narajowski | M | 71 | - | |
| Edward L. Erickson | M | 76 | 6 Jahre | |
| Philip S. Devine | M | 57 | 9 Jahre | |
| Christopher D. Thibodeau | M | 52 | - | |
| Mark D. Myslinski | M | 67 | 5 Jahre | |
| Mark Shaffar | M | 71 | - | |
| Kurt Schmidt | M | - | 3 Jahre | |
| Ruth Devenyns | F | 59 | - | |
| Rudi Pauwels | M | 65 | - | |
| Francis Ota | M | 71 | 5 Jahre | |
| Jan Pensaert | M | 53 | 10 Jahre | |
| Melissa A. Thompson | M | - | - | |
| Michael K. Brawer | M | 71 | 1 Jahre | |
| Robert S. Timmins | M | 90 | 7 Jahre | |
| Denis Biju-Duval | M | 67 | 8 Jahre | |
| Jean-Marc Roelandt | M | 60 | 2 Jahre | |
| Raphaël Wisniewski | M | 54 | 8 Jahre | |
| Rudi Mariën | M | 79 | 11 Jahre | |
| Todd Druley | M | - | 1 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigtes Königreich | 26 | 38,24% |
| Belgien | 23 | 33,82% |
| Niederlande | 13 | 19,12% |
| Schweiz | 7 | 10,29% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
